Home Study Webcast
1.75 Contact Hour(s)
Friday, October 1, 2021
Sunday, October 1, 2023
ACPE Expiration Date
Monday, April 1, 2024
Pharmacist, Pharmacy Technician, Nurse
Almost 30 million Americans utilize OTC Self-Care Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for pain management, while NSAID use results in 100,000 hospitalizations and 17,000 deaths every year. Healthcare professionals have always been concerned with the relative cardiovascular and gastrointestinal safety of NSAIDs, yet our Opioid Crisis outshines those risks with its respective sensationalization and unfortunate deadly outcomes.
Whether OTC or Prescription, NSAID medications have a distinct risk-versus-benefit analysis mandated for every single patient, causing clinicians to be stuck between a rock and a hard place when deciphering just which, if any, NSAID is best for any given patient. On top of that conundrum, the COVID-19 pandemic has raised concerns even higher on whether NSAIDs can put a patient at a higher risk for Coronavirus infection, or, conversely, if NSAIDs can treat COVID-19. Join us for this dynamic discussion on "everything NSAIDs” to facilitate improved patient care for all healthcare professionals.
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.
In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.
PharmD, MBA, BCGP, CPE, CTTS
Assistant Professor, West Virginia University School of Pharmacy
This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).